Profile data is unavailable for this security.
About the company
Blue Jet Healthcare Limited is an India-based specialty pharmaceutical and healthcare ingredients and intermediates company. The Company’s operations are primarily organized in three product categories: contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). Contrast media are agents used in medical imaging to enhance the visibility of body tissues under X-rays, computed tomography (CT), magnetic resonance imaging (MRI) or ultrasound. Its high-intensity sweetener business includes development, manufacturing and marketing of saccharin and its salts. The Company’s contract development and manufacturing organization (CDMO) activity in the pharma intermediate and API business is primarily focused on collaborating with innovator pharmaceutical companies and multi-national generic pharmaceutical companies by providing them with pharma intermediates that serve as building blocks for APIs in chronic therapeutic areas.
- Revenue in INR (TTM)6.95bn
- Net income in INR1.57bn
- Incorporated1968
- Employees447.00
- LocationBlue Jet Healthcare LtdMUMBAI 400705IndiaIND
- Phone+91 2 222075307
- Websitehttps://bluejethealthcare.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innova Captab Ltd | 11.42bn | 1.06bn | 46.11bn | -- | 34.01 | -- | 37.11 | 4.04 | 23.69 | 23.69 | 236.62 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 33.38 | 25.18 | 9.30 | 8.04 | -- | 8.89 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
| Hikal Ltd | 18.03bn | 677.82m | 46.92bn | 2.06k | 69.25 | -- | 24.76 | 2.60 | 5.49 | 5.49 | 145.97 | -- | -- | -- | -- | 8,749,879.00 | -- | 5.07 | -- | 7.51 | 53.06 | 46.78 | 3.76 | 5.86 | -- | 2.45 | -- | 12.19 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
| Morepen Laboratories Ltd | 17.45bn | 1.18bn | 47.55bn | 1.62k | 37.55 | -- | 31.77 | 2.73 | 2.31 | 2.31 | 34.26 | -- | -- | -- | -- | 10,749,300.00 | -- | 7.90 | -- | 13.34 | 37.86 | 33.34 | 6.77 | 5.49 | -- | 33.34 | -- | 0.00 | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
| Aarti Drugs Ltd | 24.23bn | 1.57bn | 48.29bn | 1.06k | 30.75 | -- | 23.09 | 1.99 | 17.08 | 17.08 | 263.82 | -- | -- | -- | -- | 22,770,740.00 | -- | 9.73 | -- | 15.78 | 34.32 | 22.23 | 6.48 | 8.25 | -- | 7.28 | -- | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
| Supriya Lifescience Ltd | 5.99bn | 1.35bn | 50.33bn | 448.00 | 37.22 | -- | 33.16 | 8.40 | 16.80 | 16.80 | 74.42 | -- | -- | -- | -- | 13,370,000.00 | -- | 19.08 | -- | 24.04 | 62.75 | 57.12 | 22.58 | 24.71 | -- | 92.47 | -- | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| Aarti Pharmalabs Ltd | 19.50bn | 2.25bn | 59.63bn | 1.63k | 26.47 | -- | 19.78 | 3.06 | 24.86 | 24.86 | 215.17 | -- | -- | -- | -- | 11,983,730.00 | -- | -- | -- | -- | 44.20 | -- | 11.55 | -- | -- | 18.55 | -- | -- | -4.76 | -- | 12.10 | -- | -- | -- |
| Orchid Pharma Ltd | 8.81bn | 1.12bn | 71.16bn | 872.00 | 61.31 | -- | 48.56 | 8.08 | 22.89 | 22.89 | 180.65 | -- | -- | -- | -- | 10,101,540.00 | -- | -0.9734 | -- | -1.40 | 40.67 | 40.74 | 12.78 | -2.40 | -- | 6.08 | -- | -- | 23.05 | 6.43 | 73.59 | 5.84 | 57.79 | -- |
| Sun Pharma Advanced Research Co Ltd | 684.05m | -3.89bn | 71.31bn | 409.00 | -- | -- | -- | 104.25 | -11.97 | -11.97 | 2.11 | -- | -- | -- | -- | 1,672,501.00 | -- | -61.70 | -- | -119.31 | 59.81 | 74.49 | -568.24 | -163.40 | -- | -208.33 | -- | -- | -68.36 | -16.21 | -73.96 | -- | 15.40 | -- |
| Procter & Gamble Health Ltd | 11.51bn | 2.01bn | 85.00bn | 1.41k | 42.31 | 15.79 | 37.22 | 7.38 | 121.01 | 121.01 | 693.20 | 324.24 | 1.21 | 2.71 | 11.45 | -- | 21.21 | -- | 29.28 | -- | 71.29 | -- | 17.46 | -- | 1.90 | 386.94 | 0.0175 | -- | -6.37 | -- | -12.42 | -- | -- | -- |
| Shilpa Medicare Ltd | 11.84bn | 447.57m | 88.20bn | 931.00 | 180.56 | -- | 57.62 | 7.45 | 5.00 | 5.00 | 133.55 | -- | -- | -- | -- | 12,716,850.00 | -- | 2.84 | -- | 3.65 | 65.19 | 60.08 | 3.79 | 7.03 | -- | 1.56 | -- | 10.76 | 9.66 | 9.44 | 198.15 | -22.26 | -9.26 | -- |
| Blue Jet Healthcare Ltd | 6.95bn | 1.57bn | 91.16bn | 447.00 | 57.90 | -- | 49.83 | 13.12 | 9.08 | 9.08 | 40.07 | -- | -- | -- | -- | 15,547,110.00 | -- | -- | -- | -- | 55.54 | -- | 22.65 | -- | -- | 124.37 | -- | -- | -1.30 | -- | 2.33 | -- | -- | -- |
| F D C Ltd | 20.45bn | 3.14bn | 94.82bn | 6.66k | 30.31 | -- | 26.67 | 4.64 | 19.21 | 19.21 | 124.56 | -- | -- | -- | -- | 3,070,786.00 | -- | 12.05 | -- | 13.73 | 65.55 | 61.54 | 15.37 | 15.85 | -- | 75.15 | -- | 1.09 | 8.92 | 12.24 | 57.30 | 12.45 | 16.93 | -- |
| Strides Pharma Science Ltd | 42.09bn | -475.19m | 125.59bn | 3.07k | -- | -- | 90.91 | 2.98 | -5.44 | 0.4871 | 460.14 | -- | -- | -- | -- | 13,731,270.00 | -- | -1.68 | -- | -2.97 | 60.18 | 51.39 | -1.68 | -3.36 | -- | 1.24 | -- | -- | 9.83 | 13.21 | 43.57 | -- | -18.52 | -3.58 |
| Marksans Pharma Ltd | 22.68bn | 3.34bn | 127.44bn | 2.00k | 38.14 | -- | 30.74 | 5.62 | 7.37 | 7.37 | 50.09 | -- | -- | -- | -- | 11,339,960.00 | -- | 14.62 | -- | 18.52 | 53.39 | 50.52 | 14.71 | 14.03 | -- | 32.19 | -- | 6.17 | 17.56 | 16.84 | 17.80 | 32.62 | 73.86 | 64.38 |
| Granules India Ltd | 47.01bn | 4.92bn | 132.68bn | 4.12k | 26.98 | -- | 18.87 | 2.82 | 20.29 | 20.29 | 193.87 | -- | -- | -- | -- | 11,403,970.00 | -- | 10.68 | -- | 16.18 | 56.89 | 48.83 | 10.47 | 11.82 | -- | 6.95 | -- | 8.96 | -0.123 | 14.61 | -21.54 | 11.38 | 6.38 | 8.45 |
| Akums Drugs and Pharmaceuticals Ltd | -100.00bn | -100.00bn | 133.05bn | 7.39k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.32 | -- | -104.25 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Blue Jet Healthcare Ltd's reporting currency: Indian Rupee INR
2.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 3.28m | 1.89% |
| ICICI Prudential Asset Management Co. Ltd.as of 31 Aug 2024 | 921.53k | 0.53% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Aug 2024 | 367.34k | 0.21% |
| Edelweiss Asset Management Ltd.as of 31 Aug 2024 | 325.00k | 0.19% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Aug 2024 | 49.14k | 0.03% |
| Aditya Birla Sun Life Insurance Co. Ltd.as of 30 Aug 2024 | 28.67k | 0.02% |
| Groww Asset Management Ltd.as of 31 Aug 2024 | 252.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 31 Aug 2024Source: FactSet Research Systems Inc.
